News - SSS International Clinical Research

News / 11.07.2019

Clinical studies regarding AML - a short overview

Despite intensive research, the treatment options for AML have changed only slightly in the last few decades with cytarabine and anthracyclines as cornerstones. Modifications in dose and schedule and ...

News / 19.06.2019

Restructuring of Romanian health authority breathes new life into clinical trials in Romania

Over the past years pharmaceutical companies had to face unpredictable and increasingly long response times for clinical trial approvals in Romania. Now, the NAMMD published very encouraging figures s...

News / 01.04.2019

New recommendation of the Bundesärztekammer strengthens practical aspects in the qualification of investigators

From 01. April 2019 on the recommendations for the assessment of the investigator’s qualifications in clinical studies published by the `Arbeitskreis Ethikkommissionen´ has been replaced by a new vers...

Events / 25.10 - 26.10.2018

SSS presented on TÜV SÜD conference about challenges in clinical investigations due to the new medical device regulation (MDR)

On this year's TÜV SÜD medical device forum taking place in Hamburg´s historic "Kaffeebörse" SSS were invited to share their view in a presentation about the conduct of clinical investigations under t...

News / 14.06.2018

25th anniversary of SSS: Well equipped for the digital future

The medium-sized contract research institute SSS Clinical Research celebrates its 25th anniversary. SSS benefits greatly from its IT-driven approach and is therefore well prepared for the digital futu...

Events / 18.04 - 19.04.2018

SSS at "Deutsche Biotechnologietage 2018"

This years "Deutschen Biotechnologietage" have been taken place for the eighth time. More than 900 participants from start-ups, universities, companies, funding bodies and public institutions met on t...

News / 20.11.2017

Pharmacovigilance: the countdown is on

As early as 2010, the EU Regulation No. 1235/2010 kicked off a reorientation in drug safety. The aim was and is to create more transparency with standardized approval procedures and to provide faster ...

News / 03.08.2017

More manpower for research

From July 2017, Dr. Lars Behrend (45) will fill the role of COO, covering the key areas of financial management, controlling and business development. Lars Behrend holds a diploma in biology and a PhD...

Meet us at